{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:07:39Z","timestamp":1762520859814,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,6]],"date-time":"2021-02-06T00:00:00Z","timestamp":1612569600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","award":["440010\/2018-7"],"award-info":[{"award-number":["440010\/2018-7"]}],"id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contemporary Clinical Trials Communications"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.conctc.2021.100745","type":"journal-article","created":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T05:00:35Z","timestamp":1612933235000},"page":"100745","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Randomized, phase 1\/2, double-blind pioglitazone repositioning trial combined with antifungals for the treatment of cryptococcal meningitis \u2013 PIO study"],"prefix":"10.1016","volume":"22","author":[{"given":"Ludmila","family":"Gouveia-Eufrasio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noelly Queiroz","family":"Ribeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julliana Ribeiro Alves","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marliete Carvalho","family":"da Costa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u00fazia Castro Peres","family":"Em\u00eddio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gustavo Jos\u00e9 Cota","family":"de Freitas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3186-885X","authenticated-orcid":false,"given":"Paulo Henrique Fonseca","family":"do Carmo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara Alves","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Carlos Maia Dornelas","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia Mara Vitorino","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0260-353X","authenticated-orcid":false,"given":"Victor Augusto","family":"Teixeira Leoc\u00e1dio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanessa Caroline","family":"Randi Magalh\u00e3es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indiara","family":"Penido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5426-0655","authenticated-orcid":false,"given":"Leonardo Soares","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia Frota","family":"Rabelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio Augusto","family":"de Almeida Faria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8086-8058","authenticated-orcid":false,"given":"Maria Rita","family":"Teixeira Dutra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8295-8049","authenticated-orcid":false,"given":"Ma\u00edra","family":"Aspahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila","family":"de Paula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dirce In\u00eas","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M\u00e1rcia Gregory","family":"Tavares Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia Antunes","family":"de Andrade Zambelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2344-6158","authenticated-orcid":false,"given":"Andr\u00e9 Augusto","family":"Gomes Faraco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1349-9413","authenticated-orcid":false,"given":"Isabela","family":"da Costa C\u00e9sar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glauciene Prado","family":"Alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L\u00edvia Fulg\u00eancio","family":"da Cunha Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nalu Teixeira","family":"de Aguiar Peres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1108-5666","authenticated-orcid":false,"given":"Daniel Assis","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.conctc.2021.100745_bib1","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"issue":"1","key":"10.1016\/j.conctc.2021.100745_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2016.167","article-title":"Cryptococcal meningitis: epidemiology, immunology, diagnosis and therapy","volume":"13","author":"Williamson","year":"2017","journal-title":"Nat. Rev. Neurol."},{"issue":"6","key":"10.1016\/j.conctc.2021.100745_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0006479","article-title":"Searching for a change: the need for increased support for public health and research on fungal diseases","volume":"12","author":"Rodrigues","year":"2018","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.conctc.2021.100745_bib4","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S1473-3099(17)30243-8","article-title":"Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis","volume":"17","author":"Rajasingham","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.conctc.2021.100745_bib5","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.tim.2011.07.010","article-title":"Cryptococcus gattii: a resurgent fungal pathogen","volume":"19","author":"Chaturvedi","year":"2011","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.conctc.2021.100745_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-43941-w","article-title":"Mortality due to Cryptococcus neoformans and Cryptococcus gattii in low-income settings: an autopsy study","volume":"9","author":"Hurtado","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.conctc.2021.100745_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-04588-7","article-title":"High-dose fluconazole in combination with amphotericin B is more efficient than monotherapy in murine model of cryptococcosis","volume":"7","author":"Santos","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.conctc.2021.100745_bib8","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/13543776.2018.1503252","article-title":"Future perspectives for cryptococcosis treatment","volume":"28","author":"Santos-Gandelman","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.conctc.2021.100745_bib9","first-page":"1","article-title":"Antifungal therapy and management of complications of cryptococcosis due to Cryptococcus gattii","volume":"22","author":"Chen","year":"2013","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.conctc.2021.100745_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ijantimicag.2017.04.005","article-title":"Atorvastatin as A promising anticryptococcal agent","volume":"49","author":"Ribeiro","year":"2017","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.conctc.2021.100745_bib11","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijantimicag.2019.06.020","article-title":"Pioglitazone as an adjuvant of Amphotericin B for the treatment of cryptococcosis","volume":"54","author":"Ribeiro","year":"2019","journal-title":"Int. J. Antimicrob. Agents"},{"key":"10.1016\/j.conctc.2021.100745_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.ppat.1003980","article-title":"PPAR\u03b3 agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human mal\u00e1ria","volume":"10","author":"Serghides","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.conctc.2021.100745_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1159\/000120028","article-title":"Low-dose chemotherapy in combination with COX-2 inhibitors and PPAR-gamma agonists in recurrent high-grade gliomas - a phase II study","volume":"73","author":"Hau","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.conctc.2021.100745_bib14","doi-asserted-by":"crossref","first-page":"787","DOI":"10.2165\/11316510-000000000-00000","article-title":"Liver safety in patients with type 2 diabetes treated with pioglitazone: results from a 3-year, randomized, comparator-controlled study in the US. Randomized controlled trial","volume":"32","author":"Tolman","year":"2009","journal-title":"Drug Saf."},{"key":"10.1016\/j.conctc.2021.100745_bib15","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1111\/dme.12736","article-title":"Pioglitazone: reports of its death are greatly exaggerated - it is alive and ready to resume saving lives","volume":"32","author":"Ryder","year":"2015","journal-title":"Diabet. Med."},{"key":"10.1016\/j.conctc.2021.100745_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13229-018-0241-5","article-title":"A pilot dose finding study of pioglitazone in autistic children","volume":"9","author":"Capano","year":"2018","journal-title":"Mol. Autism."},{"key":"10.1016\/j.conctc.2021.100745_bib17","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1161\/CIRCULATIONAHA.118.034763","article-title":"Heart failure after ischemic stroke or transient ischemic attack in insulin-resistant patients without diabetes mellitus treated with pioglitazone","volume":"138","author":"Young","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.conctc.2021.100745_bib18","doi-asserted-by":"crossref","first-page":"502","DOI":"10.2174\/1871530318666180423121833","article-title":"Pioglitazone therapy and fractures: systematic review and meta- analysis","volume":"18","author":"Pavlova","year":"2018","journal-title":"Endocr. Metab. Immune Disord. - Drug Targets"},{"key":"10.1016\/j.conctc.2021.100745_bib19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00380-018-1143-3","article-title":"Effect of pioglitazone on cardiometabolic profiles and safety in patients with type 2 diabetes undergoing percutaneous coronary artery intervention: a prospective, multicenter, randomized trial","volume":"33","author":"Tanaka","year":"2018","journal-title":"Heart Ves."},{"key":"10.1016\/j.conctc.2021.100745_bib20","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00432-018-2791-5","article-title":"Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial","volume":"145","author":"Cramer","year":"2019","journal-title":"J. Canc. Res. Clin. Oncol."},{"key":"10.1016\/j.conctc.2021.100745_bib21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.clml.2019.01.006","article-title":"Adding oral pioglitazone to standard induction chemotherapy of acute myeloid leukemia: a randomized clinical trial","volume":"19","author":"Ghadiany","year":"2019","journal-title":"Clin. Lymphoma, Myeloma & Leukemia"},{"key":"10.1016\/j.conctc.2021.100745_bib22","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.dsx.2018.04.013","article-title":"Effect of pioglitazone on decreasing of proteinuria in type 2 diabetic patients with nephropathy","volume":"13","author":"Pourshabanan","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.conctc.2021.100745_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1001\/jamaneurol.2019.0079","article-title":"Pioglitazone therapy in patients with stroke and prediabetes: a post hoc analysis of the IRIS randomized clinical trial","volume":"76","author":"Spence","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.conctc.2021.100745_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1093\/mmy\/myv104","article-title":"Reproducibility of CSF quantitative culture methods for estimating rate of clearance in cryptococcal meningitis","volume":"54","author":"Dyal","year":"2016","journal-title":"Med. Mycol."},{"key":"10.1016\/j.conctc.2021.100745_bib25","first-page":"159","article-title":"Treatment for HIV-associated cryptococcal meningitis","volume":"7","author":"Tenforde","year":"2018","journal-title":"Cochrane"},{"key":"10.1016\/j.conctc.2021.100745_bib26","first-page":"87","article-title":"Determina\u00e7\u00e3o do tamanho da amostra em pesquisas experimentais na \u00e1rea de sa\u00fade","volume":"29","author":"Weyne","year":"2004","journal-title":"Arq. Med. ABC"},{"year":"2017","series-title":"Division of AIDS (DAIDS) Table for Grading the Severity of Adult and Pediatric Adverse Events","key":"10.1016\/j.conctc.2021.100745_bib28"},{"key":"10.1016\/j.conctc.2021.100745_bib29","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/S1473-3099(16)00074-8","article-title":"Efficacy of adjunctive sertraline for the treatment of HIV-associated cryptococcal meningitis: an open-label dose-ranging study","volume":"16","author":"Rhein","year":"2016","journal-title":"Lancet Infect. Dis."}],"container-title":["Contemporary Clinical Trials Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421000478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451865421000478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T13:02:53Z","timestamp":1762520573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451865421000478"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":28,"alternative-id":["S2451865421000478"],"URL":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100745","relation":{},"ISSN":["2451-8654"],"issn-type":[{"type":"print","value":"2451-8654"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Randomized, phase 1\/2, double-blind pioglitazone repositioning trial combined with antifungals for the treatment of cryptococcal meningitis \u2013 PIO study","name":"articletitle","label":"Article Title"},{"value":"Contemporary Clinical Trials Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.conctc.2021.100745","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100745"}}